- Description
- Benefits
- Risks
- Additional information
- Research
Description
HGH Fragment 176-191 is a synthetic peptide fragment derived from the C-terminal region of human growth hormone (HGH). It is specifically studied in laboratory environments for its role in lipolysis (fat metabolism) and metabolic pathway research, without exhibiting the full biological activity of native growth hormone.
In controlled research settings, HGH Fragment 176-191 has been investigated for its ability to target fat metabolism pathways, making it a compound of interest in studies focused on adipose tissue regulation, lipid breakdown, and energy utilisation mechanisms.
As demand for pure peptides in Ireland and across Europe continues to grow, HGH Fragment 176-191 is commonly included in research areas such as:
- Fat metabolism and lipolysis research
- Adipose tissue signalling pathways
- Energy expenditure and metabolic studies
- Growth hormone fragment-specific activity research
This product is supplied as a high-purity research peptide, intended strictly for scientific and laboratory use.
Disclaimer: This product is strictly for research purposes only and is not for human consumption.
Technical Information – HGH Fragment 176-191
| Specification | Details |
|---|---|
| Product Name | HGH Fragment 176-191 |
| Compound Type | Synthetic peptide fragment |
| Origin | Derived from human growth hormone (C-terminal fragment) |
| Amino Acid Sequence | Residues 176–191 of HGH |
| Functional Class | Lipolytic research peptide |
| Mechanism of Action | Targets fat metabolism pathways (research context) |
| Biological Targets | Adipose tissue, metabolic signalling systems |
| Format | Lyophilised powder |
| Purity | Research-grade (high purity) |
| Storage | Refrigerated (2–8°C, protected from light) |
| Application | Laboratory research use only |
* Images for illustration purposes only
Further Refrences: PubChem Entry
Researched Benefits & Focus Areas – HGH Fragment 176-191
1. Lipolysis & Fat Metabolism Research
HGH Fragment 176-191 has been studied for:
- Stimulation of lipolysis in experimental models
- Influence on fat breakdown pathways
- Research into reduced lipid accumulation mechanisms
Reference basis: Derived from preclinical studies investigating growth hormone fragments and their role in fat metabolism and adipose tissue regulation.
2. Adipose Tissue Targeting
Research has explored:
- Interaction with fat cell signalling pathways
- Effects on adipocyte metabolism
- Selective activity in fat tissue models
Reference basis: Based on experimental metabolic studies examining adipose tissue-specific signalling and peptide activity.
3. Metabolic Pathway Modulation
HGH Fragment 176-191 is used in:
- Energy expenditure research models
- Studies on metabolic efficiency and regulation
- Exploration of hormone fragment-specific signalling
Reference basis: Supported by biochemical research into growth hormone derivatives and metabolic signalling pathways.
4. Reduced GH-Related Activity Research
Unlike full HGH, this fragment is studied for:
- Minimal interaction with growth hormone receptors
- Focus on fat metabolism without anabolic GH effects
- Separation of lipolytic vs growth pathways
Reference basis: Derived from research comparing full-length HGH with specific peptide fragments and their biological activity profiles.
Disclaimer: These are research-based findings only. This product is not intended for human use or consumption.
Researched Risks & Considerations – HGH Fragment 176-191
1. Limited Human Clinical Data
- Most research is preclinical
- Lack of extensive human trials
- Long-term effects remain uncertain
Reference basis: Reflects the current stage of growth hormone fragment research.
2. Metabolic System Complexity
- May influence multiple metabolic pathways
- Potential for unintended biological effects in models
Reference basis: Based on studies examining interconnected metabolic signalling systems.
3. Off-Target Effects
- Possible interaction with non-target tissues
- Broad systemic influence in experimental environments
Reference basis: Derived from research into peptide distribution and signalling across biological systems.
4. Experimental Classification
- Not approved for medical or therapeutic use
- Requires controlled laboratory handling
- Strictly limited to research environments
Reference basis: Based on regulatory frameworks governing research peptides in EU and international markets.
Disclaimer: These risks are based on available research data only. This product is strictly a research peptide and not for human consumption.
Additional information
| Weight | 23 kg |
|---|---|
| Dimensions | 12 × 23 × 56 cm |
| Quantity | 1 Vial, 1 Kit (10 Vials) |
Related Products
FEATURED PRODUCTS
BEST SELLING PRODUCTS
LATEST PRODUCTS
TOP RATED PRODUCTS